Science n Tech

CHENNAI: ICMR's National Institute for Research in Tuberculosis has initiated a study to assess the efficacy of a four-month tuberculosis treatment regimen as compared to the existing six-month regimen.The trial study is being…
Read More...

WASHINGTON: Researchers have developed a new N95 face mask that can not only reduce COVID-19 spread but also kill the SARS-CoV-2 virus upon contact with it.The mask can potentially be worn longer, causing less plastic waste as it does…
Read More...

NITI Aayog, the policy think tank of the government of India, has tabled a proposal for the creation of a single, self-regulatory body for online fantasy sports. In its draft proposal, titled ‘Guiding Principles for the Uniform…
Read More...

Bengaluru: The GSAT-24 satellite, built by ISRO for NewSpace India Limited (NSIL), was successfully launched by French company Arianespace from Kourou in French Guiana (South America) on Thursday. GSAT-24 is a 24-Ku band communication…
Read More...

Hyderabad: Bharat Biotech International Limited (BBIL) on Friday announced that its COVID-19 vaccine Covaxin has proven to be safe, well-tolerated and highly immunogenic in paediatric subjects in phase II/III study. A press release from…
Read More...

STATE TIMES NEWS LEH: Ladakh Territorial Congress Committee headed by its president Nawang Rigzin Jora paid tributes to former Union Minister P. Namgyal on his 2nd death anniversary in Leh on Wednesday.Recounting P. Namgyal's tremendous…
Read More...

New Delhi: After sending missions to the Moon and Mars, the ISRO is now readying a spacecraft to orbit Venus to study what lies below the surface of the solar system's hottest planet, and also unravel the mysteries under the Sulfuric Acid…
Read More...

STATE TIMES NEWS Indore: There will four eclipses in 2021, including one total solar eclipse and one total lunar eclipse, but only two will be visible from India, Ujjain-based Jiwaji Observatory's Superintendent Dr Rajendraprakash Gupt…
Read More...

Ahmedabad: Over 750 volunteers have been administered the first dose of Bharat Biotech's COVID-19 vaccine 'Covaxin' as part of its phase-3 trials at a city hospital, and none of them have experienced any side effects so far, a senior…
Read More...

Los Angeles: The body's protective antibodies against the novel coronavirus target a different part of the virus in severe cases of COVID-19 than they do in mild forms of the disease, and wane significantly within several months of…
Read More...